Reply to Mohlin et al.: High levels of EPAS1 are closely associated with key features of low-risk neuroblastoma
- PMID: 29233947
- PMCID: PMC5754814
- DOI: 10.1073/pnas.1718429115
Reply to Mohlin et al.: High levels of EPAS1 are closely associated with key features of low-risk neuroblastoma
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6137-E6146. doi: 10.1073/pnas.1700655114. Epub 2017 Jul 10. Proc Natl Acad Sci U S A. 2017. PMID: 28696319 Free PMC article.
-
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms.Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10856-E10858. doi: 10.1073/pnas.1716644115. Epub 2017 Dec 12. Proc Natl Acad Sci U S A. 2017. PMID: 29233939 Free PMC article. No abstract available.
References
-
- Holmquist-Mengelbier L, et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell. 2006;10:413–423. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
